All In Biotech

Drug Trial Radar · NCT07317934

Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

A Phase III, Randomized, Open-Label, Active-Controlled Study to Evaluate the Efficacy and Safety of Subretinal Injection of LX102 in Participants With Neovascular Age-Related Macular Degeneration - The STELLAR Trial

Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 388 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

388

Planned (sponsor's estimate)

Start

Jan 14, 2026

Primary completion

Mar 2028

Study completion Jun 4, 2032

Sponsor

Sponsor type
Industry
First posted
Jan 5, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 50 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase III, randomized, open-label, active-controlled study to evaluate the efficacy and safety of subretinal injection of LX102 in participants with neovascular age-related macular degeneration. The study will evaluate a single subretinal injection of LX102 compared to an active comparator. The primary endpoint of this study is the mean change from D0 in BCVA based on an average at weeks 48 and 56.

Conditions

  • Neovascular Age-Related Macular Degeneration (nAMD)
  • Wet AMD

Interventions

  • LX102Genetic

    Study eyes will receive a single subretinal injection of LX102.

  • AfliberceptBiological

    Study eyes will receive 3 monthly loading doses of aflibercetp 2mg IVT and aflibercept 2mg IVT every 8 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from D0 in BCVA based on an average at weeks 48 and 56.Time frame: Week 56

Locations

36 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of University of Science and Technology of China

    Hefei, Anhui, China · Recruiting

  • Beijing Aier-Intech Eye Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Southwest Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • The First Affiliated Hospital of Jinan University

    Guangzhou, Guangdong, China · Recruiting

  • Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong

    Shantou, Guangdong, China · Recruiting

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    Zhongshan, Guangdong, China · Recruiting

  • Hebei Eye Hospital

    Xingtai, Hebei, China · Recruiting

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Recruiting

  • Tongji Hospital Tongji Medical College of HUST

    Wuhan, Hubei, China · Recruiting

  • Central Theater Command General Hospital of PLA

    Wuhan, Hubei, China · Recruiting

  • The Second Xiangya Hospital, Central South University

    Changsha, Hunan, China · Recruiting

  • Aier Eye Hospital Group Co., LTD. Changsha Aier Eye Hospital

    Changsha, Hunan, China · Recruiting

  • The Affiliated Eye Hospital of Nanjing Medical University

    Nanjing, Jiangsu, China · Recruiting

  • Xuzhou First People's Hospital

    Xuzhou, Jiangsu, China · Recruiting

  • The Second Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • Shenyang Fourth People's Hospital

    Shenyang, Liaoning, China · Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Recruiting

  • Shandong Eye Hospital

    Jinan, Shandong, China · Recruiting

  • Qingdao Eye Hospital Affiliated to Shandong First Medical University

    Qingdao, Shandong, China · Recruiting

  • Eye & ENT Hospital of Fudan University

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanghai General Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanxi Eye Hospital

    Taiyuan, Shanxi, China · Recruiting

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China · Recruiting

  • Xi 'an People's Hospital (Xi 'an No.4 Hospital)

    Xi’an, Shanxi, China · Recruiting

  • The First Affiliated Hospital of Air Force Medical University

    Xi’an, Shanxi, China · Recruiting

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China · Recruiting

  • Tianjin Eye Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Tianjin Medical University Eye Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Zhejiang Provincial People's Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • The Eye Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.